Brown Capital Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Sell |
7,109,995
-353,972
| -5% | -$1.2M | 0.7% | 41 |
|
|
2025
Q1 | $29.9M | Sell |
7,463,967
-782,643
| -9% | -$3.14M | 0.9% | 39 |
|
|
2024
Q4 | $53.5M | Sell |
8,246,610
-1,246,864
| -13% | -$8.09M | 1.24% | 30 |
|
|
2024
Q3 | $52.6M | Sell |
9,493,474
-1,893,910
| -17% | -$10.5M | 1.13% | 31 |
|
|
2024
Q2 | $63.5M | Sell |
11,387,384
-634,630
| -5% | -$3.54M | 1.28% | 25 |
|
|
2024
Q1 | $80.7M | Buy |
12,022,014
+5,689
| +0% | +$38.2K | 1.43% | 26 |
|
|
2023
Q4 | $110M | Sell |
12,016,325
-1,544,155
| -11% | -$14.1M | 1.64% | 24 |
|
|
2023
Q3 | $74.9M | Buy |
13,560,480
+2,828,797
| +26% | +$15.6M | 1.15% | 31 |
|
|
2023
Q2 | $91.6M | Buy |
10,731,683
+2,130,260
| +25% | +$18.2M | 1.3% | 30 |
|
|
2023
Q1 | $79M | Buy |
8,601,423
+3,493,545
| +68% | +$32.1M | 1.18% | 31 |
|
|
2022
Q4 | $52.2M | Buy |
5,107,878
+701,417
| +16% | +$7.16M | 0.86% | 32 |
|
|
2022
Q3 | $64.9M | Buy |
+4,406,461
| New | +$64.9M | 0.91% | 32 |
|